nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Unifying Hypothesis for Scleroderma: Identifying a Target Cell for Scleroderma
|
Mahoney, William M. |
|
2010 |
13 |
1 |
p. 28-36 |
artikel |
2 |
Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
|
Laat, Bas de |
|
2010 |
13 |
1 |
p. 70-76 |
artikel |
3 |
B-cell–Targeted Therapy for the Fibrotic Complications of Systemic Sclerosis
|
Woodrick, Robert |
|
2010 |
13 |
1 |
p. 1-3 |
artikel |
4 |
Biomarkers in the Management of Scleroderma: An Update
|
Abignano, Giuseppina |
|
2010 |
13 |
1 |
p. 4-12 |
artikel |
5 |
Biomarkers of Scleroderma Lung Disease: Recent Progress
|
Hant, Faye N. |
|
2010 |
13 |
1 |
p. 44-50 |
artikel |
6 |
Imatinib and the Treatment of Fibrosis: Recent Trials and Tribulations
|
Gordon, Jessica |
|
2010 |
13 |
1 |
p. 51-58 |
artikel |
7 |
Is Testing for Antiphosphatidylethanolamine Antibodies Clinically Useful?
|
Sanmarco, Marielle |
|
2010 |
13 |
1 |
p. 81-85 |
artikel |
8 |
New Insights into the Biology and Pathobiology of Beta2-Glycoprotein I
|
Giannakopoulos, Bill |
|
2010 |
13 |
1 |
p. 90-95 |
artikel |
9 |
Primary Thrombosis Prophylaxis in Antiphospholipid Antibody–Positive Patients: Where Do We Stand?
|
Barbhaiya, Medha |
|
2010 |
13 |
1 |
p. 59-69 |
artikel |
10 |
The Genetics of Scleroderma
|
Martin, Javier |
|
2010 |
13 |
1 |
p. 13-20 |
artikel |
11 |
The Scleroderma Kidney: Progress in Risk Factors, Therapy, and Prevention
|
Bussone, Guillaume |
|
2010 |
13 |
1 |
p. 37-43 |
artikel |
12 |
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials
|
Iwamoto, Naoki |
|
2010 |
13 |
1 |
p. 21-27 |
artikel |
13 |
Update on Antiphospholipid Syndrome in Children
|
Myones, Barry L. |
|
2010 |
13 |
1 |
p. 86-89 |
artikel |
14 |
Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients
|
Petri, Michelle |
|
2010 |
13 |
1 |
p. 77-80 |
artikel |